Translational Aspects of Sphingolipid Metabolism in Renal Disorders

Alaa Abou Daher, Tatiana El Jalkh, Assaad A. Eid, Alessia Fornoni, Brian Marples, Youssef Zeidan

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Sphingolipids, long thought to be passive components of biological membranes with merely a structural role, have proved throughout the past decade to be major players in the pathogenesis of many human diseases. The study and characterization of several genetic disorders like Fabry's and Tay Sachs, where sphingolipid metabolism is disrupted, leading to a systemic array of clinical symptoms, have indeed helped elucidate and appreciate the importance of sphingolipids and their metabolites as active signaling molecules. In addition to being involved in dynamic cellular processes like apoptosis, senescence and differentiation, sphingolipids are implicated in critical physiological functions such as immune responses and pathophysiological conditions like inflammation and insulin resistance. Interestingly, the kidneys are among the most sensitive organ systems to sphingolipid alterations, rendering these molecules and the enzymes involved in their metabolism, promising therapeutic targets for numerous nephropathic complications that stand behind podocyte injury and renal failure.

Original languageEnglish (US)
JournalInternational Journal of Molecular Sciences
Volume18
Issue number12
DOIs
StatePublished - Nov 25 2017

Fingerprint

Sphingolipids
metabolism
Metabolism
disorders
Biological membranes
Kidney
pathogenesis
insulin
Molecules
metabolites
Insulin
apoptosis
kidneys
Cell death
Metabolites
organs
enzymes
molecules
Enzymes
membranes

Keywords

  • Fabry’s disease
  • podocytes
  • renal failure
  • renal injury
  • sphingolipid metabolism
  • sphingolipids

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Translational Aspects of Sphingolipid Metabolism in Renal Disorders. / Daher, Alaa Abou; Jalkh, Tatiana El; Eid, Assaad A.; Fornoni, Alessia; Marples, Brian; Zeidan, Youssef.

In: International Journal of Molecular Sciences, Vol. 18, No. 12, 25.11.2017.

Research output: Contribution to journalReview article

Daher, Alaa Abou ; Jalkh, Tatiana El ; Eid, Assaad A. ; Fornoni, Alessia ; Marples, Brian ; Zeidan, Youssef. / Translational Aspects of Sphingolipid Metabolism in Renal Disorders. In: International Journal of Molecular Sciences. 2017 ; Vol. 18, No. 12.
@article{998bf1e5199a424cbf3933d1d24c11a1,
title = "Translational Aspects of Sphingolipid Metabolism in Renal Disorders",
abstract = "Sphingolipids, long thought to be passive components of biological membranes with merely a structural role, have proved throughout the past decade to be major players in the pathogenesis of many human diseases. The study and characterization of several genetic disorders like Fabry's and Tay Sachs, where sphingolipid metabolism is disrupted, leading to a systemic array of clinical symptoms, have indeed helped elucidate and appreciate the importance of sphingolipids and their metabolites as active signaling molecules. In addition to being involved in dynamic cellular processes like apoptosis, senescence and differentiation, sphingolipids are implicated in critical physiological functions such as immune responses and pathophysiological conditions like inflammation and insulin resistance. Interestingly, the kidneys are among the most sensitive organ systems to sphingolipid alterations, rendering these molecules and the enzymes involved in their metabolism, promising therapeutic targets for numerous nephropathic complications that stand behind podocyte injury and renal failure.",
keywords = "Fabry’s disease, podocytes, renal failure, renal injury, sphingolipid metabolism, sphingolipids",
author = "Daher, {Alaa Abou} and Jalkh, {Tatiana El} and Eid, {Assaad A.} and Alessia Fornoni and Brian Marples and Youssef Zeidan",
year = "2017",
month = "11",
day = "25",
doi = "10.3390/ijms18122528",
language = "English (US)",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Translational Aspects of Sphingolipid Metabolism in Renal Disorders

AU - Daher, Alaa Abou

AU - Jalkh, Tatiana El

AU - Eid, Assaad A.

AU - Fornoni, Alessia

AU - Marples, Brian

AU - Zeidan, Youssef

PY - 2017/11/25

Y1 - 2017/11/25

N2 - Sphingolipids, long thought to be passive components of biological membranes with merely a structural role, have proved throughout the past decade to be major players in the pathogenesis of many human diseases. The study and characterization of several genetic disorders like Fabry's and Tay Sachs, where sphingolipid metabolism is disrupted, leading to a systemic array of clinical symptoms, have indeed helped elucidate and appreciate the importance of sphingolipids and their metabolites as active signaling molecules. In addition to being involved in dynamic cellular processes like apoptosis, senescence and differentiation, sphingolipids are implicated in critical physiological functions such as immune responses and pathophysiological conditions like inflammation and insulin resistance. Interestingly, the kidneys are among the most sensitive organ systems to sphingolipid alterations, rendering these molecules and the enzymes involved in their metabolism, promising therapeutic targets for numerous nephropathic complications that stand behind podocyte injury and renal failure.

AB - Sphingolipids, long thought to be passive components of biological membranes with merely a structural role, have proved throughout the past decade to be major players in the pathogenesis of many human diseases. The study and characterization of several genetic disorders like Fabry's and Tay Sachs, where sphingolipid metabolism is disrupted, leading to a systemic array of clinical symptoms, have indeed helped elucidate and appreciate the importance of sphingolipids and their metabolites as active signaling molecules. In addition to being involved in dynamic cellular processes like apoptosis, senescence and differentiation, sphingolipids are implicated in critical physiological functions such as immune responses and pathophysiological conditions like inflammation and insulin resistance. Interestingly, the kidneys are among the most sensitive organ systems to sphingolipid alterations, rendering these molecules and the enzymes involved in their metabolism, promising therapeutic targets for numerous nephropathic complications that stand behind podocyte injury and renal failure.

KW - Fabry’s disease

KW - podocytes

KW - renal failure

KW - renal injury

KW - sphingolipid metabolism

KW - sphingolipids

UR - http://www.scopus.com/inward/record.url?scp=85049412854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049412854&partnerID=8YFLogxK

U2 - 10.3390/ijms18122528

DO - 10.3390/ijms18122528

M3 - Review article

C2 - 29186855

AN - SCOPUS:85035787545

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

ER -